DAUNORUBICIN for B precursor type acute leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 274 adverse event reports in the FDA FAERS database where DAUNORUBICIN was used for B precursor type acute leukaemia.

Most Reported Side Effects for DAUNORUBICIN

Side Effect	Reports	%	Deaths	Hosp.
Febrile neutropenia	1,311	13.3%	168	683
Pyrexia	645	6.6%	117	419
Neutropenia	631	6.4%	95	300
Sepsis	515	5.2%	207	298
Off label use	462	4.7%	132	149
Pneumonia	402	4.1%	213	176
Bacterial infection	400	4.1%	272	102
Drug ineffective	375	3.8%	137	133
Septic shock	363	3.7%	174	225
Thrombocytopenia	347	3.5%	85	152
Pancytopenia	345	3.5%	89	135
Clostridium difficile colitis	331	3.4%	218	116
Myelosuppression	319	3.2%	25	106
Hypotension	298	3.0%	97	260
Product use in unapproved indication	280	2.8%	80	116